Drug Shortage Report for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Report ID | 23172 |
Drug Identification Number | 02443902 |
Brand name | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL |
Common or Proper name | EMTRICITABINE/TENOFOVIR DISOPROXIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE |
Strength(s) | 300MG 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BT |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-19 |
Actual start date | |
Estimated end date | 2019-01-11 |
Actual end date | 2018-12-18 |
Shortage status | Avoided shortage |
Updated date | 2018-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v56 | 2018-05-01 | French | Compare |
v55 | 2018-05-01 | English | Compare |
v54 | 2018-03-01 | English | Compare |
v53 | 2018-02-28 | French | Compare |
v52 | 2018-02-28 | English | Compare |
v51 | 2018-02-28 | French | Compare |
v50 | 2018-02-28 | English | Compare |
v49 | 2018-02-27 | French | Compare |
v48 | 2018-02-27 | English | Compare |
v47 | 2018-02-23 | French | Compare |
v46 | 2018-02-23 | English | Compare |
v45 | 2018-02-02 | French | Compare |
v44 | 2018-02-02 | English | Compare |
v43 | 2018-01-09 | English | Compare |
v42 | 2018-01-08 | French | Compare |
v41 | 2018-01-08 | English | Compare |
v40 | 2018-01-03 | English | Compare |
v39 | 2018-01-02 | French | Compare |
v38 | 2018-01-02 | English | Compare |
v37 | 2017-12-30 | English | Compare |